Bioventus (BVS) Other Non-Current Assets (2021 - 2022)
Bioventus' (BVS) quarterly Other Non-Current Assets came in at $2.8 million in Q4 2022, down 94.45% YoY from $50.0 million in Q4 2021, and down 94.45% on a QoQ basis from $50.0 million in Q2 2022.
Bioventus (BVS) Other Non-Current Assets (2021 - 2022) Analysis & Trends
Bioventus (BVS) has 2 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q4 2022.
- Quarterly Other Non-Current Assets fell 94.45% year-over-year to $2.8 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.8 million (down 94.45% YoY) and the FY2022 annual result came in at $2.8 million, down 94.45% from the prior year.
- Other Non-Current Assets slipped to $2.8 million in Q4 2022, from $50.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $50.0 million in Q4 2021 to a low of $2.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Bioventus | 968.49 Mn | 939.04 Mn | 105.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.78 Mn |
| Apr 2, 2022 | 50.00 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Oct 2, 2021 | 50.00 Mn |